R&D News | pharmaphorum

News

Close-up image of a firm handshake between two colleagues

Nordic Nanovector to merge with APIM after Betalutin fail

Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics.<

News

GSK plans phase 3 for hepatitis B drug bepirovirsen, despite...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undete

News

Closeup of X-ray photography of human brain

NRG announces £16m Series A for IND for Parkinson’s and ALS

A £16 million Series A financing – led by Omega Funds – has been announced by the innovative neuroscience company

News

Sanofi signs $1.2bn research alliance with AI specialist Ins...

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 billion.

News

J&J, Idorsia plan filings for aprocitentan data in resistant...

People whose blood pressure remains stubbornly high despite current drug treatment and are at increased risk of complications such as kidney disease and stroke could have another treatment

News

Chasing Novartis, Amgen ushers Lp(a) drug into phase 3

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move a

Nordic Nanovector to merge with APIM after Betalutin fail

GSK plans phase 3 for hepatitis B drug bepirovirsen, despite...

NRG announces £16m Series A for IND for Parkinson’s and ALS

Sanofi signs $1.2bn research alliance with AI specialist Ins...

J&J, Idorsia plan filings for aprocitentan data in resistant...

Chasing Novartis, Amgen ushers Lp(a) drug into phase 3

Moderna's Q1 revenues rocket, thanks to ex-US sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks